CDRH Transparency: 515 Program Initiative Status Update

<!– –> <!– Page Last Updated: 02/17/2012 –> Page Last Updated: 02/17/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Public Workshop

The Food and Drug Administration (FDA) is announcing a public Workshop entitled “Design and Methodology for Postmarket Surveillance Studies under Section 522 of the Federal Food, Drug and Cosmetic Act.” This workshop is open to all interested parties, including professionals in the scientific community interested in advancing the infrastructure and methodology for postmarket surveillance studies….

Avastin (bevacizumab): Counterfeit Product

<!– –> <!– Page Last Updated: 02/14/2012 –> Page Last Updated: 02/14/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.